Table 3.
Antimicrobial susceptibility test patterns of bacterial pathogens isolated from dacryocystitis infection, University of Gondar Eye Specialized Hospital, Northwest Ethiopia, Gondar, Ethiopia from 2011 to 2012
| Bacterial isolates | No. (%) | Pattern | Common antibiotics tested, No. (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMOX | CIP | CN* | MET* | NA | CAF | ERY* | PEN* | TTC | SXT | CEF | |||
| S .aureus | 6(19.4) | S | 5(83.3) | 5(83.3) | 6(100.0) | - | 5(83.3) | 6(100.0) | 6(100.0) | 4(66.7) | 4(66.7) | 3(50.0) | 4(66.7) | 6(100.0) |
| R | 1(16.7) | 1(16.7) | 0(0.0) | - | 1(16.7) | 0(0.0) | 0(0.0) | 2(33.3) | 2(33.3) | 3(50.0) | 2(33.3) | 0(0.0) | ||
| CNS | 9(29.0) | S | 9(100.0) | 7(77.8) | 5(55.6) | - | 9(100.0) | 9(100.0) | 7(77.8) | 9(100) | 6(66.7) | 7(77.8) | 6(66.7) | 8(88.9) |
| R | 0(0.0) | 2(22.2) | 4(44.4) | - | 0(0.0) | 0(0.0) | 2(22.2) | 0(0.0) | 3(33.3) | 2(22.2) | 3(33.3) | 1(11.1) | ||
| S. pnemoniae | 2(6.5) | S | 0(0.0) | 2(100.0) | 1(50.0) | - | 2(100.0) | 2(100.0) | 1(50.0) | 2(100) | 2(100) | 0(0.0) | 2(100) | 2(100) |
| R | 2(100.0) | 0(0.0) | 1(50.0) | - | 0(0.0) | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 2(100.0) | 0(0.0) | 0(0.0) | ||
| Entrobacter spp. | 2(6.5) | S | 2(100.0) | 1(50.0) | 1(50.0) | - | - | 0(0.0) | 1(50.0) | 1(50.0) | 1(50.0) | 2(100.) | 0(0.0) | 2(100) |
| R | 0(0.0) | 1(50.0) | 1(50.0) | - | - | 2(100.0) | 1(50.0) | 1(50.0) | 1(50.0) | 0(0.0) | 2(100) | 0(0.0) | ||
| E .coli | 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 0(0.0) | 1(100.0) | - | - | 0(0.0) | 1(100) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 0(0.0) | - | 1(100.0) | 0(0.0) | - | - | 1(100.0) | 0(0.0) | 0(0.0) | ||
| K. pnemoniae | 2(6.5) | S | 1(50.0) | 1(50.0) | 2(100.0) | 2(100.0) | - | 1(50.0) | 2(100.0) | - | - | 1(50.0) | 2(100.) | 1(50.0) |
| R | 1(50.0) | 1(50.0) | 0(0.0) | 0(0.0) | - | 1(50.0) | 0(0.0) | - | - | 1(50.0) | 0(0.0) | 1(50.0) | ||
| Pseudomonas spp. | 3(9.7) | S | 2(66.7) | 1(33.3) | 2(66.7) | 2(66.7) | - | 2(66.7) | 2(66.7) | - | - | 2(66.7) | 2(66.7) | 3(100.) |
| R | 1(33.3) | 2(66.7) | 1(33.3) | 1(33.3) | - | 1(33.3) | 1(33.3) | - | - | 1(33.3) | 1(33.3) | 0(0.0) | ||
| Citrobacter spp. | 1(3.2) | S | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 1(100.0) | - | - | 1(100) | 1(100) | 1(100) |
| R | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | - | 0(0.0) | 0(0.0) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
| H.influenzae | 2(6.5) | S | 2(100.0) | 0(0.0) | 2(100.0) | 2(100.0) | - | 2(100.0) | 1(50.0) | - | - | 1(50.0) | 1(50.0) | 2(100.0) |
| R | 0(0.0) | 2(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 1(50.0) | - | - | 1(50.0) | 1(50.0) | 0(0.0) | ||
| P.vulgaris | 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 1(100.0) | - | - | 1(100) | 1(100) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 0(0.0) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
| P. mirabilis | 1(3.2) | S | 0(0.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 0(0.0) | - | - | 1(100.0) | 1(100) | 1(100) |
| R | 1(100) | 1(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 1(100) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
| Providencia spp | 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 0(0.0) | - | 1(100.0) | 1(100.0) | - | - | 0(0.0) | 0(0.0) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 1(100) | - | 0(0.0) | 0(0.0) | - | - | 1(100) | 1(100) | 0(0.0) | ||
| Total | 31(100) | S | 25(80.6) | 19(61.3) | 23(74.2) | 10(83.3) | 17(89.5) | 27(87.1) | 23(74.2) | 16(84.2) | 13(68.4) | 22(71.0) | 23(74.2) | 29(93.5) |
| R | 6(19.4) | 12(38.7) | 8(25.8) | 2(16.7) | 2(10.5) | 4(12.9) | 8(25.8) | 3(15.8) | 6(31.6) | 6(29.0) | 8(25.8) | 2(6.5) | ||
Keys: AMP- Ampicillin, AMOX-Amoxicillin, CIP- Ciprofloxacin, CN- Gentamycin, MET- Methicillin, NA-Nalidic Acid, CAF-Chloramphinicol, ERY- Erythromycin, VAN- Vancomycin, PEN-penicillin, TTC- Tetracycline, SXT- Co-trimoxazole, CEF-Ceftriaxone. *Percentage calculation is based on column total [19] denominator.